Promoter holding
64.27%
SR
Shivalik Rasayan Limited - Due diligence report
A 360° intelligence report on Shivalik Rasayan: trust score, financial health, credit view, compliance, directors, growth and distress signa…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Shivalik Rasayan — 360° Intelligence Report
Generated from MCA filings & public records74/100
Trust Score
Moderate
Shivalik Rasayan is assessed as Moderate with a Trust Score of 74/100. Shivalik Rasayan is an active public limited indian non-government company incorporated in 1979, operating in the Agriculture sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Shivalik Rasayan Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
40/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
80/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
- Moderate gearing (D/E 38%).
- Profitable - internal accruals available.
Charges position: 9 open (110.20 cr) · 9 satisfied (21.54 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 5 | 48.0 cr |
| Citi Bank N.A. | 3 | 48.0 cr |
| Industrial Finance Corporation Of India | 5 | 48.0 cr |
| Punjab National Bank | 1 | 48.0 cr |
| The Pradeshiya Industrtial & Investment Corporation Up Ltd | 1 | 48.0 cr |
| Idbi Bank Limited | 2 | 48.0 cr |
Compliance Score: 40/100 Caution Indicated
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: SEBI.
- Litigation present in 3 court forum(s).
- 1 auditor resignation(s) filed - latest: Rai Qimat & Associates on 2023-09-29.
- 2 active GST registration(s).
Legal cases on record (3)
05
Director Intelligence
Stability score: 80/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| RAMIT MADAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VIMAL KUMAR SHRAWAT | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHAIVAL SAURABH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAHUL BISHNOI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SURESH KUMAR SINGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAVI KUMAR BANSAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PARUL CHOUDHARY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUMITA DWIVEDI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VINOD KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHAM GOEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJAY BANSAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANGEETA BISHNOI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ASHWANI KUMAR SHARMA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 13 directors on the board.
- No disqualified or deactivated DINs.
- 4 director exits in 3 years - high churn.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Growel Remedies Limited
Subsidiaries
-
Group entities
1
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Growel Remedies Limited | Holding Company | 74.00% |
| Medicamen Biotech Limited | Associate Company | 74.00% |
Key managerial personnel: VIMAL KUMAR SHRAWAT (Managing Director) · SURESH KUMAR SINGH (Whole-time director) · VINOD KUMAR (CFO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 80 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Operating for 47+ years.
Active GST registration(s).
Distress signals & risk flags
4 director exits within 2 years.
Compliance score is weak (40/100).
9 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
3 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 9 open charge(s) of 110.20 cr already registered.
- Compliance gaps should be priced into terms.
Investor view84/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events27 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
17 Dec 2024
Charge created
Others - 20.00 Lakh
27 Sep 2024
Director ceased
RAMIT MADAN
Director ceased
SHAIVAL SAURABH
Director ceased
SHAM GOEL
13 Aug 2024
Director appointed
RAMIT MADAN (Director)
Director appointed
SHAIVAL SAURABH (Director)
Director appointed
SHAM GOEL (Director)
Director ceased
HARISH PANDE
22 Jul 2024
Charge created
Hdfc Bank Limited - 20.91 Lakh
29 Dec 2023
Charge created
Others - 49.00 cr
29 Sep 2023
Charge created
Idbi Bank Limited - 17.17 Lakh
21 Apr 2023
Charge satisfied
Others
31 Mar 2023
Charge created
Citi Bank N.A. - 15.00 cr
10
Key Observations
Auto-generated from the data aboveRevenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
13 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Lasa Supergenerics | L24233MH2016PLC274202 | Khed, Maharashtra, India |
| Sol | L72900TG1998PLC030463 | Hyderabad, Telangana, India |
| Bafna Pharma | L24294TN1995PLC030698 | Madras 600 001, Tamil Nadu, India |
| Prime Pharmaceuticals Private Limited | U24231MH1995PTC092543 | Mumbai, Maharashtra, India |
| Sanzyme | U24235TG1969PTC001282 | Khairatabad, Telangana, India |
| Gujarat Themis Biosyn | L24230GJ1981PLC004878 | Valsad, Gujarat, India |
| Perfunova (International) Limited | U01122DD2005PLC004015 | Daman, Daman And Diu, India |
| Medico | L24230MH1994PLC077187 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Shivalik Rasayan before audits and certifications: compliance score 40/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Shivalik Rasayan: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Shivalik Rasayan - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Shivalik Rasayan pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Shivalik Rasayan - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Shivalik Rasayan an active company?
Shivalik Rasayan has MCA status “Active” with a compliance score of 40/100 (Caution Indicated).
Is Shivalik Rasayan financially healthy?
Shivalik Rasayan has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Shivalik Rasayan?
Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Shivalik Rasayan?
The ultimate holding entity is Growel Remedies Limited. 13 active director(s) are on record.
Does Shivalik Rasayan have loans or charges against its assets?
9 open charge(s) are registered against its assets, and 9 earlier charge(s) stand satisfied.
Is Shivalik Rasayan up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 40/100 (Caution Indicated).
Is it risky to lend to Shivalik Rasayan?
Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
